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Summary: The urinary excretion rates of free cortisol and cortisone äs well äs of their 20-dihydroisomers
have been studied in normal subjects under different physiological or pharmacological conditions. For the
estimation of steroid excretion rates, a fully automated, liquid-chromatographic method was used.
In normal subjects, the median steroid excretion rates of free cortisol, cortisone, 20-a-dihydrocortisol, 20-ß-
dihydrocortisol, 20-a-dihydrocortisone and 20-ß-dihydrocortisone were 6.7, 8.0, 9.8, 5.2, 5.7 and 1.3 /
mpl creatinine.
The excretion rates measured at three different intervals of the day followed a circadian rhythm similar to
that known for the cortisol secreting activity of the adrenal gland.
After adrenal Stimulation by i. v. application of 250 g of tetracosactide hexaacetate, (Synacthen®, corticotro-
) excretion of urinary cortisol was sigiiificantly higher than those of the other steroids.
During a 24 h infusion of corticotropiii^..^, the excretion rates of cortisol and its C-20 reduced isomers
increased to a significantly greater extent than those of cortisone and its C-20 reduced isomers.
During a fourJiour infusion of hydrocortisone, the relative increase of cortisol excretion was greater than
that of the other steroids.
During a five-hour infusion of metyrapone at different dosages, the excretion of all steroids decreased in a
; dose-deperident manner.
The present data indicate that the 20^dihydroisomers of cortisol and cortisone in human urine primarily
originate from the peripheral metabolism of cortisol rather than from adrenal secretion. A partial secretion
of the C-20-reduced isomers of cortisol by the adrenal gland and an Inhibition of 11-oxidoreductase by
corticotropin^ >24 can not be excluded. A 24 h Stimulation by corticotropin^.24 is not sufficiently chronic to
significantly induce the 20-oxidoreductase.
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Introduction
There is very little published Information on the role
of the 20-dihydroisomers of cortisol and cortisone in
human physiology. In very early publications, only
20ß-dihydrocortisol and 20-ß-dihydrocortisone were
described äs occurring in human and dog urine (l,
2). Recently, we found that both the a- and ß-isomers
of cortisol and cortisone are present in human urine
and that the -isomers are predominant (3, 4). The
origin of these urinary 20-reduced steroids obviously
is multilocal. In in vitro experiments, their formation
has been shown to occur in rat (5, 6), in dog (7) and
in human kidney (8) äs well äs in the human adrenal
cortex (9). The liver may also be involved, although
here they are rapidly metabolized to cortols and cor-
tolones (10). In the present experiments, we deter-
mined the urinary excretion rates of cortisol and
cortisone äs well äs of their 20-dihydroisomers, 20-
-dihydrocortisol, 20-ß-dihydrocortisol, 20-o^dihy^
drocortisone, and 20-ß-dihydrocortisone, under dif-
ferent conditions of Stimulation and suppression of
adrenal steroid secretion. From these in vivo data,
we can expect to obtain further Information on the
origin of these steroids that occur in human urine.
Protocols
Normal male and female students volunteered fpr the studies.
They consented to participate after the protocols had been
carefully explained to them. They had no obvious evidence of
metabolic, endocrine, renal, or hepatic disease.
Normal 24 h excretion rates
24 h urine samples were collected from 57 normal males and
females.
Infusion of hydrocortisone
In five male subjects, 50 mg of hydrocortisone-21-hemisuccinate
in 9 g/l saline were infused via an anticubital vein from 8.00 h
to 12.00 h. Urine was collected from 10.00 h to 16.00 h at two
hour intervals.
Suppression by metyrapone t
Five male subjects were studied in Iow-dose and high-dose
metyrapone experiments.
In the Iow-dose experiment, l g metyrapone ditartrate (Ciba-
Geigy, Basle, Switzerland) dissolved in 500 ml of 9 g/l saline
was infused via an antecübital vein from 8.00h to 12.00h.
Urine samples were collected from 8.00h to 18.00h at two
hour intervals.
In the high-dose experiment, 4g metyrapone ditartrate were
infused under cornparable conditions over the 5 h experirnental
period. Urine was collected under the same conditions äs in
the Iow-dose experiment.
During the high-dose experiment, 2 subjects complained of
some bürning along the course of the vein infused with mety-




The urine speciniens were stored at 4 °C during the period of
collection, with no preservatives. From the collected urines,
aliquots of about 10 ml were stored and frozen until analysis.
Analytical procedure
Urinary free steroids were estimated by an automated, liquid
Chromatographie technique, the methodological details of
which have been described elsewhere (11). Coefficients of Varia-
tion ränge between 8.7% and 17.0% for inter-assay variability
and between 1.3% and 5.2% for intra-assay variability. Assay
sensitivity is 15 nmol/1.
Circadian rhythm
From four male subjects, urine samples were collected at three
different time intervals of the day, from 12.00 to 22.00 h, from
22.00 to 8.00 h and from 8.00 to 12.00 h.
Short term Stimulation by corticotropin
After collecting fresh urines at 8.00 h, we injected 250 g of
tetracosactide hexaacetate (Synacthen®, corticotropin^) into
one male and seven female subjects intravenously, and again
collected urine specimens 4 h later.
Long term Stimulation by corticotropin
In three male subjects, urine was collected on a control day
from 7.00 h to 17.00 h. On the second day, starting at 7.00 h
tetracosactide was infused at a rate of 10 Hg in 24 hours. Urine t
was collected from 7.00 h to 17.00 h and from 17.00 h to 7.00 h.
Results
Normal 24 h excretion rates
Results of excretion rates of ürinary steroids are listed
in table l. The excretion rates are expressed relative
to creatinine excretion. A logarithmic distribution of
values was assumed. The ratio of 20-a-dihydrocorti-
sol/cortisol was 1.5.
Circadian rhythm
The relative excretion rates of the urinary steroids at
three different time intervals of the day are shown in
figure 1. The changes of the C-20-redüced steroids
parallel those of cortisol and cortisone. The ratio of
20-a-dihydrocortisol/cortisol shown in the upper part
of the figure remains constant.;
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Stimulation with corticotropin
After short term Stimulation, the relative excretion
rates of all the urinary steroids measured increased
significantly (p <0.01) (fig.2). The highest relative
increase was found for cortisol, which exhibited a
15.9-fold increase (mean value). The ratio of 20-ot-
dihydrocortisol/cortisol decreased from 2.0 to 0.58.
The changes of the relative excretion rates of steroids
during the long term infusion of corticotropin are
shown in figure 3. After the control day, excretion
rates of cortisol and its C-20-reduced metabolites
drastically increased during the first period of infu-
sion and again still further increased during the
second period of infusion. The ratio of 20-a dihydro-
cortisol/cortisol changed from 2.4 under basal condi-
tions to 0.9 after the second period of corticotropin
infusion. Although excretion rates of cortisone and
its metabolites also increased during the infusion pe-
riod of corticotropin, their relative increases were
significantly lower than those of cortisol and its
metabolites. Thus, the cortisol/cortisone ratio of 0.8
under basal conditions changed to 15.7 after the
second period of corticotropin infusion. Data for 20-
-dihydrocortisone were not measurable during the
infusion period, since the correspondent peaks were
not discernible against the neighbouring high peaks
of 20- -dihydrocortisol.
"δ
Tab. 1. Relative 24-h urinary excretion rates of cortisol and £
cortisone and their C-20-reduced isomers from normal 0 |
subjects. Results expressed s lower limit, median and ^τ^
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20a-Dihydrocortisol 6.5 9.8 14.0 I J
20a-Dihydrocortisone 2.9 5.7 11.4 Jj i
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20 -Dihydrocortisone 0.5 1.3 3.9
Cortisol 1.8 6.7 14.0
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Fig. 1. Relative urinary excretion rates of cortisol iid cortisone
and their C-20-reduced isomers (mean ± SEM) at three
different time intervals of the day. The ratio of 20-a-
dihydrocortisol/cortisol in the upper part.
SEM = Standard error of mean;
1 = 20-a dihydrocortisol;
2 = 20ia-dihydrocortisone;
3 = 20- -dihydrocortisol;
4 = 20- -dihydrocortisone;
5 = cortisol;
6 = cortisone.
Fig. 2. Relative urinary excretion rates of cortisol and cortisone
and their C-20-reduced isomers (mean ± SEM) before
and after adrenal short-tenn Stimulation by tetracosac-
tide (Synacthen®) in eight normal subjects. Abbrevi-
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Relative urinary excretion rates of cortisol and cortisone
and their C-20-reduced isomers (mean ± SEM) before
and during a one-day infusion of tetracosactide (Synac-
then®) in three normal subjects. Abbreviations are s
in flg. 1.
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Infusion of hydrocortisone
During hydrocortisone infusion, the excretion rates
of all steroids continuously increased up to the end
of infusion (flg. 4). Maximum values in the period
between 10.00 and 12.00 h were about 25% ofthose
found after the second period of corticotropiri infu-
sion (fig. 3). After infusion, excretion rates feil
towards normal values. The 20-a-dihydrocortisol/
Cortisol ratio was lower than l during hydrocortisone
infusion and higher than l after the infusion. The
cortisol/cortisone ratio changed from 2.7 during the
first two hours of infusion to 1.2 during 14.00 and
16.00h.
Suppression by metyrapone
The changes of the relative excretion rates of steroids
during low-dose infusion of metyrapone are shown














Fig. 4. Relative urinary excretion rates of Cortisol and cortisone
and their C-20-reduced isomers (mean ± SEM) during
and after a four-hour infusion of hydrocortisone-21-
hemisuccinate in five normal subjects. Abbreviations
are s in fig. 1.
the first two hours of infusion. Values were lower
than the detection limit from 10.00 to 14.00 h. Excre-
tion rates started to increase up from 16.00 h. In the
high dose experiment, the initial fall of excretion rates
was steeper and the time of suppression was longer
than in the low-dose experiment.
Discussion
The reference intervals of the excretion rates of the
urinary free steroids measured are in accordance with
those recently evaluated in the methodological experi-
ments(ll).
The excretion rates of the C-20-reduced steroids
(fig. 1) follow the circadian rhythm kriown for the
cortisol secreting activity of the adrenal gland (12).
As indicated by the constant 20-a-dihydrocortisol/
cortisol ratio, the mechanisms dictating the C-20 re-
duction of the cortisol and cortisone molecule are
not influenced by a circadian rhythm.
Both after adrenal short-term and long-term Stimula-
tion by corticotropin (figs. 2 and 3), there is a signifi-
cantly higher increase of urinary cortisol compared
with all other steroids. This finding accords with the
corresponding data on 6 -hydroxycortisol (13) and
the hypothesis that under conditions of a rapid, exag-
gerated increase of cortisol in blood, s occurs after
corticotropin administration, the binding capacity of
transcortin is exceeded and a disproportionately large
amount of unbound secreted cortisol appears in the
urine. It is striking that the dissociation between
cortisol and cortisone, the product of C-l l oxidation,
is much more pronounced than that between cortisol
and 20-a-dihydrocortisol, the product of C-20 reduc-
tion. This finding riiay be explained by a higher activ-
ity of C-20-oxidoreductase compared with that of the
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Fig. 5. Relative urinary excretion rates of cortisol and cortisone and their C-20-reduced isomers (mean ± SEM) during and
after a four hour infusion of 200 mg/h of metyrapone in five normal subjects. Abbreviations are s in fig. 1.
J. Clin. Chem. Clin. Biochem. / Vol. 25,1987 / No. 6
Eisenschmid et al.: 20-Dihydroisomers of Cortisol and cortisone in human urine 349
20-a-dihydrocortisol by the adrenal gland or by an
inhibitory effect of corticotropin on 11-oxidoreduc-
tase. Under conditions of chronic hypercorticoidism,
äs occurs in patients with Cushing's syndrome, we
found an inverse ratio of Cortisol to 20-oc-dihydrocor-
tisol, i. e. excretion rates of the C-20 reduced product
of cortisol were significantly higher than those of
cortisol itself (4). This shift of cortisol metabolism
was explained by a trophic effect of cortisoJ on its
own metabolizing enzymes (13). Obviously, the one-
day infusion of corticotropin in our experiments is
not sufficiently chronic to induce such a metabolic
shift.
The fmdings of the hydrocortisone experiment princi-
pally accord with those of the corticotropin exper-
iment, i. e. a pronounced excretion of cortisol com-
pared with that of its metabolites. However, the disso-
ciation between cortisol and cortisone is distinctly
lower (cortisol/cortisone ratio of 2.7) if compared
with the dissociation observed under the conditions
of the one-day infusion of corticotropin (cortisol/
cortisone ratio of 15.9). This finding favours the
above mentioned hypothesis that corticotropin may
inhibit 11-oxidoreductase.
Metyrapone is known to block cortisol biosynthesis
by competitive Inhibition of adrenal 11-monooxygen-
ase (14,15) and of the "cholesterol-cleavage enzyme"
(16). Under the present conditions of metyrapone
infusion, plasma cortisol was found to be suppressed
within two hours after Start of infusion (17). Plasma
levels increased again from 15.00 h in the low dose
experiment and from 16.00 h in the high dose exper-
iment (17). The present fmdings on steroid excretion
rates principally reflect the time course of plasma
cortisol. An activating effect of metyrapone on 20-
oxidoreductase, äs described by Levin et al. (18),
could not be confirmed by the present data.
In conclusion, the present data indicate that cortisone
and its 20-reduced isomers äs well äs the 20-reduced
isomers of cortisol in human urine primarily originale
from peripheral metabolism of cortisol rather than
by adrenal secretion. When considering the relatively
high excretion rates measured for 20-a-dihydrocorti-
sol under the conditions of a 24 h infusion of cortico-
tropin (fig. 3), it cannot be excluded that urinary 20-
a-dihydrocortisol is at least partially due to adrenal
secretion, äs postulated by Touchstone et al. on the
basis of in vitro studies (9).
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